首页|期刊导航|Integrative Medicine Discovery|Targeted neurotransmitter metabolomics-based evaluation of the effects of electroacupuncture on diabetic peripheral neuropathy in mice

Targeted neurotransmitter metabolomics-based evaluation of the effects of electroacupuncture on diabetic peripheral neuropathy in miceOA

中文摘要

Background:Diabetic peripheral neuropathy(DPN)is a prevalent and debilitating complication of diabetes mellitus,lacking effective treatment options.Despite unclear underlying mechanisms,electroacupuncture(EA)shows promise in relieving DPN symptoms.Neurotransmitter dysregulation is central to DPN pathophysiology.This study aimed to investigate EA’s effects on DPN via targeted neurotransmitter metabolomics.Methods:A streptozotocin-induced mouse model of DPN was developed,and EA treatment was administered for two weeks to assess the therapeutic potential of EA.Following the collection of sciatic nerve samples,LC-MS-based targeted metabolomics analyses investigations were performed to examine alterations in DPN-associated neurotransmitter metabolism brought on by EA therapy.Multivariate statistical analyses were employed to assess metabolite expression patterns,using cluster heatmaps to display neurotransmitter expression results.KEGG pathway analyses were also used to explore the functional classifications of these neurotransmitters and associated metabolic pathways.Results:Targeted neurotransmitter-focused metabolomics analyses led to the identification of 34 putative biomarkers associated with EA treatment,of which 5 showed significant changes,such as beta-alanine(increased by 80.37%,P=0.0004)and kynurenine(decreased by 29.36%,P=0.0163).KEGG pathway analysis indicated that changes in the abundance of these metabolites were associated with the cAMP signaling pathway,neuroactive ligand-receptor interactions,the synaptic vesicle cycle,and other pathways.Conclusion:The results indicate that EA can efficiently regulate neurotransmitter metabolism and restore peripheral nerve function,suggesting a feasible non-pharmacological strategy for DPN treatment and warranting clinical translation.

Zhu Jin;Wen Li;Qiu-Yue Wang;Jin-Ling Dai;Shuetling Chung;Jie Tu

Department of Acupuncture,Shanghai Seventh People’s Hospital,Shanghai 200437,ChinaDepartment of Acupuncture,Shanghai Seventh People’s Hospital,Shanghai 200437,ChinaDepartment of Acupuncture,Shanghai Seventh People’s Hospital,Shanghai 200437,ChinaDepartment of Acupuncture,Shanghai Seventh People’s Hospital,Shanghai 200437,ChinaDepartment of Acupuncture,Shanghai Seventh People’s Hospital,Shanghai 200437,ChinaDepartment of Acupuncture,Shanghai Seventh People’s Hospital,Shanghai 200437,China

医药卫生

diabetic peripheral neuropathyelectroacupuncturetargeted metabolomicsneurotransmittersmetabolite profiling

《Integrative Medicine Discovery》 2025 (23)

P.1-10,10

supported by Pudong New Area Science and Technology Development Fund Special Research Project on the Livelihood of Institutions(No.PKJ2023-Y03)Pudong New Area Chinese Medicine Senior Teacher Training Program(No.PDZY-2023-0801)Talents Training Program of the Seventh People’s Hospital,Shanghai University of Traditional Chinese Medicine(No.JY2024-08).

10.53388/IMD202509023

评论